足部弓状态与按血管区域靶向血运重建对慢性肢体威胁性缺血影响的竞争风险分析
本研究纳入580例因慢性肢体威胁性缺血伴足部溃疡或坏疽行膝下动脉血运重建的患者,采用竞争风险方法评估大截肢风险。多变量分析显示,与完整足部弓相比,不完整或未见足部弓是膝下血运重建后大截肢的独立预测因素;在完整足部弓存在时,按血管区域靶向血运重建的大截肢风险更低。亚组分析提示,腔内血运重建患者中完整足部弓和按血管区域靶向血运重建均与较低大截肢风险相关。
要点
- 足部弓不完整或未见是膝下血运重建后大截肢的独立预测因素。
- 完整足部弓存在时,按血管区域靶向血运重建可降低大截肢风险。
- 腔内血运重建患者中,完整足部弓和按血管区域靶向血运重建均与较低大截肢风险相关。
核心结论
- 竞争风险分析显示,通畅的足部弓对保肢有显著影响。
- 接受腔内手术的患者亚组可能从按血管区域靶向血运重建中获益最大。
研究设计与样本
- 本研究为系列病例分析,纳入580例因慢性肢体威胁性缺血伴足部溃疡或坏疽行膝下动脉血运重建的患者。
- 其中腔内血运重建407例,外科血运重建173例。
- 采用竞争风险方法评估膝下血运重建后大截肢风险,并分别对腔内和开放外科血运重建患者进行亚组分析。
主要发现
- 2年生存率为65.1%,保肢率为76.1%。
- 多变量竞争风险分析显示,C反应蛋白≥10 mg/dL、糖尿病、类风湿关节炎、受累血管区域数量增加以及足部弓不完整或完全未见(与完整足部弓相比)是膝下血运重建后大截肢的独立预测因素。
- 与完整足部弓相比,足部弓不完整的大截肢风险SHR为2.131(95%CI 1.282-3.543),未见足部弓的SHR为3.022(95%CI 1.553-5.883)。
- 在实现按血管区域靶向血运重建的患者中,存在完整足部弓者相比无完整足部弓者大截肢风险更低(校正SHR 0.463;95%CI 0.240-0.894)。
- 腔内血运重建亚组中,完整足部弓(SHR 0.509;95%CI 0.286-0.905)和按血管区域靶向血运重建(SHR 0.613;95%CI 0.394-0.956)与较低大截肢风险相关。
临床怎么用
- 在膝下动脉血运重建前评估足部弓状态,足部弓不完整或未见提示大截肢风险升高。
- 对于存在完整足部弓的患者,可考虑按血管区域靶向血运重建以降低大截肢风险。
- 腔内血运重建患者中,完整足部弓和按血管区域靶向血运重建均与较低大截肢风险相关,可作为策略参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the context of chronic limb-threatening ischemia, the prognostic impact of angiosome-targeted revascularization and of the status of the pedal arch are debated. METHODS: This series includes 580 patients who underwent endovascular (n = 407) and surgical revascularization (n = 173) of the infrapopliteal arteries for chronic limb-threatening ischemia associated with foot ulcer or gangrene. The risk of major amputation after infrapopliteal revascularization was assessed by a competing risk approach. A subanalysis was made separately for patients who underwent endovascular or open surgical revascularization. RESULTS: At 2 years, survival was 65.1% and leg salvage was 76.1%. Multivariable competing risk analysis showed that C-reactive protein ≥10 mg/dL, diabetes, rheumatoid arthritis, increased number of affected angiosomes, and the incomplete or total absence of pedal arch compared with complete pedal arch (CPA) were independent predictors of major amputation after infrapopliteal revascularization. Multivariable analysis showed increasing risk estimates of major amputation in patients with incomplete (subdistribution hazard ratio [SHR], 2.131; 95% confidence interval [95% CI], 1.282-3.543) and no visualized pedal arch (SHR, 3.022; 95% CI, 1.553-5.883) compared with CPA. Pedal arch was important even if angiosome-targeted revascularization was achieved: Angiosome-directed revascularization in presence of CPA had a lower risk of major amputation (adjusted SHR, 0.463; 95% CI, 0.240-0.894) compared with angiosome-directed revascularization without CPA. In the subanalysis, among patients who underwent endovascular revascularization, CPA (SHR, 0.509; 95% CI, 0.286-0.905) and angiosome-targeted revascularization (SHR, 0.613; 95% CI, 0.394-0.956) were associated with a lower risk of major amputation. CONCLUSIONS: Competing risk analysis showed that a patent pedal arch had significant impact on leg salvage and that the subset of patients undergoing endovascular procedure may most benefit of an angiosome-targeted revascularization.
引用
- Settembre N, Biancari F, Spillerova K, et al. Competing Risk Analysis of the Impact of Pedal Arch Status and Angiosome-Targeted Revascularization in Chronic Limb-Threatening Ischemia. Ann Vasc Surg. 2020. PMID: 32278873. doi:10.1016/j.avsg.2020.03.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。